Predicting blood clot return after stopping blood thinners
Part of Heart & circulation, Lungs & breathing clinical trials.
This study uses a special 3D lung scan (V/Q SPECT/CT) to see if leftover blockages in your lungs can predict if another blood clot will come back. You may be eligible if your doctor has decided it's safe to stop your blood thinners after 3 to 6 months of treatment for a first blood clot.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have had a confirmed blood clot in your lungs (pulmonary embolism).
- You have been treated with blood thinners for 3 to 6 months and your doctor plans to stop them now.
- You do not have a strong reason to stay on blood thinners, such as cancer or a second blood clot that happened for no obvious reason.
- You do not have other ongoing health issues like obesity, chronic lung disease, inflammatory disease, liver or kidney problems that would require longer blood thinners.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how long people need blood-thinning medicine after a serious blood clot in the lungs. It might help doctors find the best treatment length for each person.
This study helps you and your doctor decide together whether to continue blood thinners after a first unexpected blood clot. You join after 3 to 6 months of treatment to discuss your options.
This study compares different real-world treatments for a serious but stable type of blood clot in the lungs (called intermediate-high risk pulmonary embolism). It aims to see which treatments work best in everyday patients, including those with other health conditions.
This study looks at people with interstitial lung disease (a lung scarring condition) who have new or worsening symptoms that might be caused by a blood clot in the lungs (pulmonary embolism). Doctors want to find better ways to predict which patients actually have a clot, which could lead to earlier and more accurate treatment.
This study looks at whether a new way of grouping patients with blood clots in the lungs (pulmonary embolism) can better predict their outcomes. If you join, your health will be tracked for 30 days to see how well this new system works.
This study follows people who had a serious blood clot in their lungs that also affected their heart's right side. It tests how their ability to walk and move changes over 6 months, helping doctors understand recovery better.
Hear when a new Pulmonary Embolism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.